Tag: Cycloserine/lurasidone

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Cycloserine/lurasidone

NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 ...

Added to Collection on: 2021-03-29 05:03:45

Tags for this article:

Medical specialties
Medicine
Health
Intensive care medicine
Relief Therapeutics
Cycloserine/lurasidone
Aviptadil
Acute respiratory distress syndrome
COVID-19
Angiotensin-converting enzyme 2
Placebo
Mechanical ventilation
RELIEF THERAPEUTICS Holding AG
United States
NeuroRx Inc.

Click the tags to see associated articles and topics

View Article Details
NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored ...

Added to Collection on: 2021-04-06 04:52:30

Tags for this article:

U.S. Securities and Exchange Commission
73rd United States Congress
Agencies of the United States government
Financial markets
SEC filings
Shareholders
Corporate governance
Initial public offering
Prospectus
Securities Act
Proxy statement
Cycloserine/lurasidone
NeuroRx Inc.
Aviptadil

Click the tags to see associated articles and topics

View Article Details
Dr. Anthony Fauci Confirms ZYESAMI Phase 3 Trial with Remdesivir at Press Briefing by White ...

Added to Collection on: 2021-04-26 13:30:00

Tags for this article:

U.S. Securities and Exchange Commission
73rd United States Congress
Agencies of the United States government
Drugs
Organic compounds
SEC filings
Securities Act
Prospectus
Cycloserine/lurasidone
Proxy statement
Forward-looking statement
Securities Exchange Act

Click the tags to see associated articles and topics

View Article Details
NRx Pharmaceuticals Announces Initiation of Phase 2b Trial of BriLife™ Vaccine for Covid-19 in ...

Added to Collection on: 2021-08-09 17:15:00

Tags for this article:

Clinical trials
Medicine
Health sciences
Health
BriLife
COVID-19 vaccine
Cycloserine/lurasidone
Aviptadil
Vaccine
NRx Pharmaceuticals, Inc.

Click the tags to see associated articles and topics

View Article Details
NRx Pharmaceuticals Announces Positive Safety Report for ZYESAMI™ (aviptadil) - Yahoo Finance

Added to Collection on: 2021-08-18 15:45:00

Tags for this article:

Health sciences
Health
Aviptadil
Peptides
Clinical research
Pharmaceutical industry
Antiviral drugs
COVID-19 drug development
Cycloserine/lurasidone
Remdesivir
COVID-19 vaccine
Food and Drug Administration
NRx Pharmaceuticals, Inc.
Vasoactive intestinal peptide

Click the tags to see associated articles and topics

View Article Details
I-SPY COVID Trial Sponsored by Quantum Leap Healthcare Collaborative Suggests No ...

Added to Collection on: 2022-03-31 12:23:52

Tags for this article:

Drugs
Health sciences
Organic compounds
COVID-19 drug development
Aviptadil
Peptides
Orphan drugs
Antiviral drugs
Remdesivir
Cycloserine/lurasidone
Dexamethasone
COVID-19
NRx Pharmaceuticals, Inc.

Click the tags to see associated articles and topics

View Article Details
FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup of ...

Added to Collection on: 2022-07-01 18:13:41

Tags for this article:

Health sciences
Life Sciences
Health care
Antidepressants
Cycloserine/lurasidone
Aviptadil
Antiviral drugs
COVID-19 drug development
Remdesivir
Pfizer
Nrx
Food and Drug Administration
NRx Pharmaceuticals, Inc.

Click the tags to see associated articles and topics

View Article Details
FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup ... - PR Newswire

Added to Collection on: 2022-07-01 13:47:57

Tags for this article:

Life Sciences
Health sciences
Drugs
Antidepressants
Cycloserine/lurasidone
Aviptadil
Novartis
Pfizer
Nrx
Remdesivir
Food and Drug Administration
Relief Therapeutics
NRx Pharmaceuticals, Inc.

Click the tags to see associated articles and topics

View Article Details